NEW DELHI - An Indian company's commercialisation of human breast milk has drawn the ire of health activists and other professionals who are concerned that this "unethical" development could "open the door for many malpractices".
The Breastfeeding Promotion Network of India (BPNI) last Saturday (July 23) urged the government to cancel Bangalore-based NeoLacta Lifesciences' licence that allows the firm to sell human breast milk as a "proprietary medicine".
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
